Board Walk - January 2021.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Works matching IS 03331024 AND DT 2021 AND VI 41 AND IP 1
Results: 15
1
2
Reversion from chronic migraine to episodic migraine: A new outcome measure.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
3
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 6, doi. 10.1177/0333102420973994
- By:
- Publication type:
- Article
4
A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 33, doi. 10.1177/0333102420970889
- By:
- Publication type:
- Article
5
Combined onabotulinumtoxinA/atogepant treatment blocks activation/sensitization of high-threshold and wide-dynamic range neurons.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 17, doi. 10.1177/0333102420970507
- By:
- Publication type:
- Article
6
Nocebo response in human models of migraine: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled, two-way crossover trials in migraine without aura and healthy volunteers.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 99, doi. 10.1177/0333102420970489
- By:
- Publication type:
- Article
7
Cluster headache not responsive to sumatriptan: A retrospective study.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 117, doi. 10.1177/0333102420956705
- By:
- Publication type:
- Article
8
Erenumab does not alter cerebral hemodynamics and endothelial function in migraine without aura.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 90, doi. 10.1177/0333102420956692
- By:
- Publication type:
- Article
9
Refractory short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing responsive to anti-calcitonin gene-related peptide monoclonal antibodies: A case report.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 127, doi. 10.1177/0333102420954558
- By:
- Publication type:
- Article
10
SUNCT/SUNA in children and adolescents: Application of ICHD-3 criteria and treatment response: Case series of 13 SUNCT/SUNA pediatric cases.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 112, doi. 10.1177/0333102420954525
- By:
- Publication type:
- Article
11
Predicting the outcome of the greater occipital nerve block – an observational study on migraine patients with and without musculoskeletal cervical impairment.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 78, doi. 10.1177/0333102420954518
- By:
- Publication type:
- Article
12
Neurophysiological correlates of abnormal auditory processing in episodic migraine during the interictal period.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 45, doi. 10.1177/0333102420951509
- By:
- Publication type:
- Article
13
Adverse effects of erenumab on cerebral proliferative angiopathy: A case report.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 122, doi. 10.1177/0333102420950484
- By:
- Publication type:
- Article
14
Brain volume changes in spontaneous intracranial hypotension: Revisiting the Monro-Kellie doctrine.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 58, doi. 10.1177/0333102420950385
- By:
- Publication type:
- Article
15
Baseline tear fluid CGRP is elevated in active cluster headache patients as long as they have not taken attack abortive medication.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 69, doi. 10.1177/0333102420949858
- By:
- Publication type:
- Article